Changing the Future of Cancer Treatment Lutetium-177 Lutetium-177 is a high-performance radioisotope designed to bind with targeting molecules, precisely aiming at tumors and metastases. By delivering radiation directly to cancer cells, it minimizes damage to healthy tissues, offering a more hopeful treatment option for cancer patients. Home / Product / Isotopes / LUTETIUM-177 Connect with Our Experts Get Tailored Supply Solutions Contact Us Why Lutetium-177? Transforming the Future of Cancer Care Primo has introduced Lutetium-177 due to its remarkable therapeutic efficacy across various malignancies, including neuroendocrine tumors (NETs) and prostate cancer. Lutetium-177 targeted therapy offers a transformative alternative for patients who have exhausted conventional treatments. By improving clinical outcomes and enhancing quality of life, it demonstrates enormous potential to revolutionize cancer treatment. Product Features Quality Assurance High specific activity, no-carrier-added (n.c.a.) Lutetium-177, exceeding both USP and Ph. Eur. pharmacopeia standards. Compliant Manufacturing Compliant with cGMP regulations and has officially submitted the Drug Master File (DMF) to the U.S. FDA. Reliable Supply SHINE’s GMP manufacturing facilities are strategically located in the U.S., ensuring a reliable supply chain and minimizing dependence on external providers. SHINE’s Global Leadership SHINE is one of the few global suppliers capable of producing Ytterbium-176 (Yb-176) and is dedicated to becoming the world’s first vertically integrated manufacturer of Lutetium-177. PRODUCT INFORMATION Packaging Options 10 mL flat bottom glass vial 2 mL conical glass vial Chemical Form n.c.a. 177LuCl₃ in 0.04M HCI solution Specific Activity ≥3,000 GBq/mg at the calibration time Radiochemical Purity ≥99% as 177LuCl₃ Radionuclidic Purity ≥99% as 177Lu Radioactivity Concentration at the Calibration ～1.0 Ci/mL（ 37 GBq/mL ） cGMP Follows ICH-Q7 and FDA-21 CFR Chemical Purity Fe ≤ 0.25 μg/GBq Cu ≤ 0.5 μg/GBq Zn ≤ 0.5 μg/GBq Pb ≤ 0.5 μg/GBq 176Yb ≤ 0.1 μg/GBq Minimum Dispense 50mCi ( 1.85 GBq ) Download Specifications Contact us First Name Last name Email Phone Message 送出
